News & Press Releases
Filter by:
Trouble at the USPTO—Part II: Bracing for Impact
March 13, 2025
Life Science Intellectual Property Review included insights from Life Science Litigation Practice Chair and Patent Litigation Practice Co-chair Sige Gutman in an article discussing recent government efficiency initiatives impacting the US Patent and Trademark Office. The article addresses the potential implications for life sciences companies and considerations for how to navigate the current uncertainty.
Member Frank Gerratana was quoted by Business Insider about the potential implications of artificial intelligence for the billable hour.
Retail and Consumer Products Co-chair Chuck Samuels recently connected with The Bond Buyer about potential changes to the tax-exempt status of municipal bonds. He noted that private activity bonds (PABs) and the health care and higher education sectors are among the most vulnerable to the possible changes—particularly at the local district level.
Litigator of the Week Runners-Up and Shout-Outs
March 7, 2025
A team of attorneys in Mintz’s renowned Patent Litigation Practice, led by Intellectual Property Division Chair Michael Renaud, was recognized as a ‘Litigator of the Week Runner-Up’ by The Am Law Litigation Daily for securing a significant defense victory for Juul Labs at the US International Trade Commission. The article highlights that the “full commission affirmed an administrative law judge’s decision finding that Juul didn’t infringe upon patents held by Altria’s NJOY covering certain vaporizer and cartridge technology, preventing any potential exclusion order.”
Life Science Litigation Practice Chair and Patent Litigation Practice Co-chair Sige Gutman recently spoke with Life Sciences Intellectual Property Review about the latest federal developments impacting the US Patent and Trademark Office, including hiring freezes, layoffs, the elimination of non-essential functions, and a return-to-office directive. The article analyzes the potential implications of the changes, particularly for pharma and biotech companies, as patent pendency times are already increasing due to a high volume of recent applications.
States Advance Climate Disclosure Proposals as SEC Steps Back
February 28, 2025
ESG Practice Co-chair Jacob Hupart was quoted by Bloomberg Law in an article about how several states have introduced bills that would make large companies disclose their carbon emissions.